里昂报告预测京东健康首季业绩稳健，收入增15%至153亿，药品销售增20%，保健品和医疗器械销售增10%以上，维持“跑赢大市”评级及目标价45港元。
Source Link里昂报告预测京东健康首季业绩稳健，收入增15%至153亿，药品销售增20%，保健品和医疗器械销售增10%以上，维持“跑赢大市”评级及目标价45港元。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.